MULLICK ADAM,CROOKE ROSANNE M.,GRAHAM MARK J.,DOBIE KENNETH W.,BELL THOMAS A.,LEE RICHARD
申请号：
NZ61677912
公开号：
NZ616779A
申请日:
2012.04.27
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Disclosed is a use of a compound targeting ApoCIII in the manufacture of a medicament for a) treating, preventing, delaying or ameliorating pancreatitis in an animal； b) increasing HDL levels and/or improving the ratio of TG to HDL in an animal thereby preventing, delaying or ameliorating a cardiovascular disease, disorder, condition or symptom thereof or onset of a cardiovascular disease, disorder, condition or symptom thereof in an animal； c) increasing HDL levels and/or improving the ratio of TG to HDL in an animal thereby reducing the risk of a cardiovascular disease, disorder, condition or symptom in an animal； and/or d) treating, preventing, delaying or ameliorating chylomicronemia, wherein the compound is capable of inhibiting apolipoprotein C-III.
